Startup revolutionizes diagnostics in dermatology

Dermagnostix closes seven-figure seed round

17-Dec-2021 - Dermagnostix revolutionizes diagnostics in dermatology with its fully auto-mated "lab-in-a-box" system, which allows the technically valid performance of complex molecular assays. "Modern molecular diagnostics is a prerequisite for implementing precision medicine in dermatology. It not only ...

oncgnostics cooperates with the Medical University of Graz

Study on Head-and-Neck tumors aims to demonstrate that a diagnostic method can reliably and early detect malignant tumors using non-invasive saliva samples

23-Apr-2021 - The biotechnology company oncgnostics GmbH is researching a method for diagnosing Head-and-Neck tumors together with the clinical department for general ENT at the Medical University of Graz as part of the “OroCa-Graz” study. 550,000 people worldwide develop carcinomas of this type every year. As ...

Deep learning for faster, more accurate and safer MRI analysis

International pool invests ~ 2 Mio € in medicine start-up mediaire

17-Dec-2020 - HTGF, primeCROWD and LIFTT are part of an international round for the development of “Deep learning diagnostic” which allows faster, more accurate and safer MRI analysis. Expansion into European markets will start in 2021 accompanied by a significant expansion of product portfolio mediaire, the ...

analytica supporting program: Come be amazed by laboratory technology, analytics and biotechnology

26-Jan-2018 - From April 10 to 13, Munich is once again the meeting point of the laboratory industry: analytica, the leading international trade fair for laboratory technology, analytics and biotechnology, offers many highlights in the supporting program in addition to the exhibition and the top-class ...

BIOCRATES Life Sciences AG Acquires Metanomics Health GmbH

04-Jan-2018 - BIOCRATES Life Sciences AG announced the acquisition of Metanomics Health GmbH. Metanomics Health is a metabolomics biomarker development and healthcare services specialist based in Berlin, Germany. At the same time, the company is closing a significant financing round to support future growth. ...

Hummingbird Diagnostics and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers

16-Nov-2017 - Hummingbird Diagnostics GmbH, specialized in early disease detection using molecular markers derived from blood, and Saarland University agreed on a comprehensive framework agreement regarding an expanded collaboration in the field of molecular diagnostics. The work aims at the validation of ...

SpinDiag Raises 1.6 Mio. EUR Seed-Capital

Point-of-care screening system for antibiotic resistance to be clinically tested

20-Jul-2017 - The Freiburg-based startup SpinDiag GmbH recently closed a 1.6 Mio. EUR seed-round with three private investors. The team developed a revolutionary point-of-care screening system for testing patients for antibiotic-resistant bacteria at their admission to hospitals and almost instantly so. The ...

Innovationsstarter Fonds Hamburg and High-Tech Gründerfonds are investing together in KSK Diagnostics GmbH

Development of molecular point-of-care diagnostic tests

26-Apr-2017 - KSK Diagnostics GmbH uses its isothermal amplification technology, KDx rITA®, for the development of molecular point-of-care tests to identify pathogens and antimicrobial resistance within 30 minutes. This significantly reduces the time before therapy is started. A financing round has now been ...

GNA Biosolutions completes € 6 million financing round

Prepares for market entry with fast diagnostic instruments for hospital bugs

03-Jul-2015 - GNA Biosolutions GmbH (GNA), a manufacturer of ultrafast pathogen diagnostic instruments, will receive fresh capital of € 6 million in a series B financing round. Founded in 2010, GNA welcomes new investors Robert Bosch Venture Capital (RBVC), SHS Gesellschaft für Beteiligungsmanagement GmbH, ...

Merck Serono and Illumina Enter Strategic Collaboration for Diagnostics in Oncology

12-Mar-2015 - Merck Serono and Illumina, Inc., announced a collaboration to expand the development of a universal next-generation sequencing-based oncology diagnostic for clinical trials of targeted cancer therapies. Under the terms of the agreement, Merck Serono and Illlumina will work together to develop ...